πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 263 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8796332

Compositions and methods for controlling infections

Regents of the University of Minnesota Β· Granted Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8784870

Controlled release compositions for modulating free-radical induced damage and methods of

The Regents of the University of California Β· Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8784885

Controlled release preparation

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8748569

Peptide amphiphiles and methods to electrostatically control bioactivity of the ikvav pept

Northwestern University Β· Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8735126

Disease control with tick phospholipase A2

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8728488

Methods of inducing an immune response in a host by administering flavivirus immunogens co

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION Β· Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8722084

Controlled release preparation

Takeda Pharmaceutical Company Limited Β· Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8715689

Chimeric west nile/dengue viruses

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8715591

Microfluidic apparatus to control liposome formation

The United States of America, as Represented by the Secretary of Commerce National Institute of Standards and Technology Β· Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8680083

Controlled release corticosteroid compositions and methods for the treatment of otic disor

The Regents of the University of California Β· Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8680082

Controlled release corticosteroid compositions and methods for the treatment of otic disor

The Regents of the University of California Β· Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8673629

Recombinant Rift Valley fever (RVF) viruses and methods of use

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8673316

Avirulent, immunogenic flavivirus chimeras

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION Β· Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8668924

Wound dressing and method for controlling severe, life-threatening bleeding

Providence Health Systemβ€”Oregon Β· Granted Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8663968

Simian T-cell lymphotropic virus

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8658626

Controlled release corticosteroid compositions and methods for the treatment of otic disor

The Regents of the University of California Β· Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8648119

Controlled release immunomodulator compositions and methods for the treatment of otic diso

The Regents of the University of California Β· Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8642048

Multiple antigenic peptides immunogenic against Streptococcus pneumonia

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8642561

Peptides whose uptake by cells is controllable

The Regents of the University of California Β· Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8637050

Peptide vaccines against group A streptococci

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION Β· Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8628764

Biocontrol of storage maladies of potatoes by bacterial antagonists produced in co-culture

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8598191

Controlled release compositions of gamma-hydroxybutyrate

Supernus Pharmaceuticals, Inc. Β· Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8541221

Primate T-lymphotropic viruses

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8524247

Rabies virus-based recombinant immunocontraceptive compositions and methods of use

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted